|
Volumn 13, Issue 1, 2007, Pages 37-40
|
Clinical study on treatment of mammary cancer by Shenqi Fuzheng Injection in cooperation with chemotherapy
|
Author keywords
Cellular immune; Chemotherapy; Mammary cancer; Shenqi Fuzheng Injection
|
Indexed keywords
CHINESE DRUG;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
SHENQI FUZHENG;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CELL KILLING;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
LEUKOCYTE COUNT;
LYMPHOCYTE COUNT;
LYMPHOCYTE SUBPOPULATION;
MEGAKARYOCYTE;
MULTIPLE CYCLE TREATMENT;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLOOD CELL COUNT;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CELL DEATH;
COMPLEMENTARY THERAPIES;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DRUGS, CHINESE HERBAL;
FEMALE;
FLUOROURACIL;
HUMANS;
IMMUNITY, CELLULAR;
INJECTIONS;
LYMPHOCYTE SUBSETS;
MIDDLE AGED;
MONOCYTES;
QUALITY OF LIFE;
|
EID: 34047269085
PISSN: 16720415
EISSN: None
Source Type: Journal
DOI: 10.1007/s11655-007-0037-5 Document Type: Article |
Times cited : (14)
|
References (6)
|